Alembic Pharmaceuticals informs about press release

29 Aug 2022 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Chlorthalidone Tablets USP, 25 mg and 50 mg. The Company has enclosed press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

844.00 -8.30 (-0.97%)
29-Dec-2025 10:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.80
Dr. Reddys Lab 1265.90
Cipla 1504.90
Zydus Lifesciences 906.90
Lupin 2099.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×